Lyka Labs Limited -0.53 % Biotechnology

Trend Analysis

Loading...

Support and Resistance Levels Analysis
The current close value 28.1 is between the support and resistance channel of 26 and 32. The stock has a Sell Signal , 26 becomes a critical support to stop the fall and 32 is a immediate resistance on the upside.

Technical Indicators (3 Month duration)
Exponential Moving average 28.1
MACD value -1.6
Price range 26.90 to 46.25
Volume range 12424 to 146570
Support & Resistance 26, 32
Stock Performance
Six Months -25.9%
Five Months-33.5%
Four Months-29.4%
Three Months-33.0%
Two Months-20.8%
One Month-11.5%
Last Six Months

-25.9%

Last Five Months

-33.5%

Last Four Months

-29.4%

Last Three Months

-33.0%

Last Two Months

-20.8%

Last One Month

-11.5%

Analysis
Volume
Today's Price Range
3 Month Price Range
About Lyka Labs Limited
Lyka Labs Limited (Lyka) is an India-based healthcare company. The Company manufactures lyophilized products. The primary segment of the Company consists of pharmaceutical products /pharma related services. Lyka has two manufacturing facilities: Ankleshwar and Tarapur. It also has an R & D facility based in Chakala, Mumbai. The Company's business lines consists of: Contract Manufacturing, where Lyka undertakes manufacturing of Lyophilized Products for a number of clients Hospital Division and markets its products like Anti-infectives, which include systemic Antimalarial, Antifungal and Antibacterials for serious infections; Lyka Animal Care, where Lyka takes care of entire Veterinary market and markets its Antibiotics, Anthelmintic products, Generics; and Lyka BDR, where Lyka Manufactures and sells products to its Joint Venture company Lyka BDR. The company caters mainly to the needs of Indian market and the export turnover being below 10% of the total turnover of the company.
See stocks similar to Lyka Labs Limited in Biotechnology

Lyka Labs Limited has Sell Signal. What is your opinion on it?

{ }